Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
immunotherapy
5
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
national
clinical trials
diagnostics
medicare
merck
nivolumab
novartis
abbvie
alzheimer's disease
amgen
biogen
bristol-myers squibb
cancer
What
drug
5
×
bio
roundup
approval
new
patients
acquisitions
advantages
agency
aimmune
albert
allergy
alzheimer's
approved
awarded
bad
bar
biggest
biogen’s
biopharmaceutical
bourla
brain
brings
cancer
case
ceo
companies
company
convo
crispr
developed
disease
doses
earlier
expect
failed
failures
fda
fight
fortune
Language
unset
unknown
Current search:
immunotherapy
×
drug
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
